Skip to content
AnalystLens

James Hardie Industries Annual Report, Year Ended Mar 31, 2022

Filing Date
Filed May 17, 2022
Period End
March 31, 2022
Securities
JHXJHIUF
One revenue dollarkept$0.13
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 20-F filed May 17, 2022. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc's Annual Report on Form 20-F for fiscal year ended 31 March 2022 reports net sales of US$3,614.7 milliona, up 24% from US$2,908.7 million, with operating income of US$682.6 million, up 44%, and net income of US$459.1 million, up 75%.

Diluted earnings per share were US$1.03b versus US$0.59. Growth was driven by Price/Mix growth of 10% and volume growth of 14%, with North America Fiber Cement net sales up 25% and operating income up 27%. Gross margin was broadly flat at 36.3%, while SG&A rose 18% on investment in marketing, innovation and talent.

The company stated that US residential end-market growth is expected to continue into fiscal 2023. The balance sheet and cash flow reflect the company's asbestos obligations under the Amended and Restated Final Funding Agreement (AFFA) with the Asbestos Injuries Compensation Fund. The asbestos liability was US$1,143.7 millionc at 31 March 2022, and US$248.5 million was funded to AICF during the year.

Net cash provided by operating activities was US$757.2 milliond, capital expenditures were US$257.8 million, and dividends paid were US$484.0 million. Cash and cash equivalents were US$125.0 million and gross debt was US$886.4 million. The company plans capital expenditures of US$1.6 billion to US$1.8 billion over the next four years for a global capacity expansion program.

Governance matters flagged in the filing include the termination of CEO Dr Jack Truong on 6 January 2022, with Harold Wiens serving as interim CEO and Michael Hammes as Executive Chairman. The Board is expected to be renewed with at least two new non-executive directors and a new CEO during fiscal 2023. The filing also discloses ongoing New Zealand weathertightness litigation, for which no reserve has been recorded, and the Cridge appeal is expected to be decided no sooner than December 2022.

Key Highlights

  1. Net sales rose 24% to US$3,614.7 million, driven by Price/Mix growth of 10% and volume growth of 14%.
  2. Operating income increased 44% to US$682.6 million, and operating income margin rose 2.6 percentage points to 18.9%.
  3. Net income increased 75% to US$459.1 million; diluted EPS was US$1.03 compared with US$0.59 in the prior year.
  4. North America Fiber Cement net sales grew 25% to US$2,551.3 million, with operating income margin of 29.1%.
  5. Net cash provided by operating activities was US$757.2 million; capital expenditures were US$257.8 million and dividends paid were US$484.0 million.
  6. Asbestos liability stood at US$1,143.7 million at 31 March 2022; US$248.5 million was contributed to AICF during the year.
  7. Interim CEO Harold Wiens was appointed in January 2022 after the termination of CEO Dr Jack Truong, and the company expects a new CEO and at least two new non-executive directors in fiscal 2023.

Follow one dollar

Of each $1.00 of revenue in FY2022, James Hardie Industries kept $0.13.

  1. Revenue$3.61B100.0%
  2. Cost of revenue−$2.30B63.7%
  3. Gross profit$1.31B36.3%
  4. Operating costs−$630.9M17.5%
  5. Operating income$682.6M18.9%
  6. Interest, other & tax−$223.5M6.2%
  7. Net income$459.1M12.7%
Computed from 10-KFY2022filed May 17, 2022Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2022 revenue went

$3.61B
  • Cost of revenue: $2.30B, 64% of revenue
  • SG&A: $461.2M, 13% of revenue
  • Net income: $459.1M, 13% of revenue
  • R&D: $38.0M, 1.1% of revenue
  • Other operating costs: $131.7M, 3.6% of revenue
  • Interest, other & tax: $223.5M, 6.2% of revenue

Kept 13% as net incomeR&D $38.0M · 1.1%

Full revenue history →

Financial Statements

FY2022 against FY2021

Line itemFY2022FY2021Change
Revenue$3.61B$2.91B+24.3%
Cost of Revenue$2.30B$1.86B+23.9%
Gross Profit$1.31B$1.05B+24.9%
R&D Expenses$38.00M$34.30M+10.8%
SG&A Expenses$461.20M$389.60M+18.4%
Operating Income$682.60M$472.80M+44.4%
Net Income$459.10M$262.80M+74.7%
EPS (Basic)$1.03$0.59+74.6%
EPS (Diluted)$1.03$0.59+74.6%
Shares Outstanding (Basic)444.90M443.70M+0.3%
Shares Outstanding (Diluted)445.90M445.40M+0.1%

Frequently Asked Questions

  1. How did James Hardie perform financially in fiscal year 2022?

    Net sales increased 24% to US$3,614.7 million, operating income rose 44% to US$682.6 million, and net income grew 75% to US$459.1 million. Growth came from both price/mix and volume, with gross margin essentially flat at 36.3%.

  2. What is the company's exposure to asbestos liabilities?

    The company consolidates AICF under the AFFA and recorded an asbestos liability of US$1,143.7 million at 31 March 2022. It funded US$248.5 million to AICF during fiscal 2022 and expects to contribute approximately A$157.5 million in fiscal 2023. Annual payments are linked to free cash flow and are subject to an annual cash flow cap.

  3. What are the company's capital allocation priorities?

    The company cites preserving liquidity, investing in organic growth through capacity expansion, innovation and marketing directly to homeowners, maintaining a leverage ratio of 1-2x, and returning capital to shareholders. It returned US$309.9 million through a special dividend in April 2021 and US$174.1 million through an ordinary half-year dividend in December 2021, and expects to invest US$1.6 billion to US$1.8 billion in capital expenditures over the next four years.

  4. What leadership changes occurred during the year?

    CEO Dr Jack Truong was terminated on 6 January 2022. Harold Wiens was appointed interim CEO and Michael Hammes became Executive Chairman on an interim basis, with Anne Lloyd appointed Lead Independent Director. The filing states that the Board anticipates renewal during fiscal 2023 with at least two new non-executive directors and a new CEO.

  5. What legal risks remain outstanding?

    The New Zealand weathertightness claims remain pending. In the Cridge litigation, the trial court found in the company's favor in August 2021 and plaintiffs appealed, with a decision expected no sooner than December 2022. The Waitakere trial is not scheduled to begin until May 2023. The company has recorded no reserve for either matter, as losses are not considered probable.